Pelthos Therapeutics (PTHS) Non-Current Debt (2022 - 2026)
Pelthos Therapeutics (PTHS) posted quarterly Non-Current Debt of $131868.0 for Q2 2025, little changed year-over-year from $131868.0 in Q2 2024, and little changed quarter-over-quarter from $131868.0 in Q1 2025.
Pelthos Therapeutics (PTHS) Non-Current Debt (2022 - 2026) Analysis & Trends
Pelthos Therapeutics' Non-Current Debt history runs 4 years deep, the most recent figure standing at $131868.0 for Q2 2025.
- In Q2 2025, Non-Current Debt changed 0.0% year-over-year to $131868.0; the TTM figure through Jun 2025 stood at $131868.0 (changed 0.0% YoY), while the FY2024 annual figure was $132000.0, down 82.4% from the prior year.
- Non-Current Debt for Q2 2025 stood at $131868.0, roughly flat from $131868.0 in the prior quarter.
- The five-year high for Non-Current Debt was $750082.0 in Q4 2023, with the low at $104800.0 in Q4 2022.
- The 4-year median for Non-Current Debt is $131868.0 (2024), against an average of $216336.3.
- The sharpest annual moves came in 2023 and 2024: Non-Current Debt soared 615.73% in 2023, then plunged 82.4% in 2024.
- Pelthos Therapeutics' Non-Current Debt stood at $104800.0 in 2022, then jumped by 615.73% to $750082.0 in 2023, then slumped by 82.4% to $132000.0 in 2024, then decreased by 0.1% to $131868.0 in 2025.
- Business Quant data shows PTHS's Non-Current Debt at $131868.0 in Q2 2025, $131868.0 in Q1 2025, and $132000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.51 Bn | 78.51 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.74 Bn | 60.56 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.39 Bn | 54.26 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.15 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.78 Bn | 28.47 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.22 Bn | 26.39 Bn | - | 8.96 Bn |
| 10 | Pelthos Therapeutics | 93.05 Mn | 68.49 Mn | 21.23 Mn | 26.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 26.59 Mn |
| Jun 30, 2025 | 131,868.00 |
| Mar 31, 2025 | 131,868.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 131,868.00 |
| Jun 30, 2024 | 131,868.00 |
| Dec 31, 2023 | 750,082.00 |
| Dec 31, 2022 | 104,800.00 |